Home Cart Sign in  
Chemical Structure| 1628805-46-8 Chemical Structure| 1628805-46-8

Structure of IDH-305
CAS No.: 1628805-46-8

Chemical Structure| 1628805-46-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

IDH-305 is a selective inhibitor of IDH1 R132H and R132C with IC50 of 18 and 28 nM, respectively.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of IDH-305

CAS No. :1628805-46-8
Formula : C23H22F4N6O2
M.W : 490.45
SMILES Code : O=C1OC[C@H]([C@@H](F)C)N1C2=NC(N[C@H](C3=CC(C)=C(C4=CC(C(F)(F)F)=NC=C4)C=N3)C)=NC=C2
MDL No. :MFCD31630851
InChI Key :DCGDPJCUIKLTDU-SUNYJGFJSA-N
Pubchem ID :90415637

Safety of IDH-305

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116-IDH2R140Q/+ cells 3.8 μM Weak inhibition of 2-HG production in IDH2 mutant R140Q, IC50 of 3.8 μM ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121
HCT116-IDH2R172K/+ cells 10 μM Weak inhibition of 2-HG production in IDH2 mutant R172K, IC50 of 10 μM ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121
MCF10A-IDH1R132H/+ cells 0.020 μM Inhibition of EGF-independent proliferation, IC50 of 0.020 μM ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121
HCT116-IDH1R132H/+ cells 0.024 μM Inhibition of 2-HG production, IC50 of 0.024 μM ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121
Cholangiocarcinoma RBE cell line 5 nM 12 hours To verify the effect of IDH1 mutation on erastin-induced ferroptosis in cholangiocarcinoma cells, results showed that IDH305 reversed the promoting effect of IDH1 mutation on ferroptosis Open Med (Wars). 2022 May 6;17(1):863-870

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mouse HCT116-IDH1R132H/+ xenograft model Oral 200 mg/kg Single dose Inhibition of tumor 2-HG production, maximal inhibition of 87.2% ACS Med Chem Lett. 2017 Sep 18;8(10):1116-1121

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.04mL

0.41mL

0.20mL

10.19mL

2.04mL

1.02mL

20.39mL

4.08mL

2.04mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories